Alexander Kutz MD, MPH, MScMedical University Department, Division of General Internal and Emergency Medicine, Kantonsspital Aarau, Aarau, Switzerland; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts
Dr. Kutz is an internist and endocrinologist. His scientific work focuses on health services research using real-world data. Apart from development of integrative health care models to improve patient transition in the hospital setting, using a Swiss health care claims database, he also focuses on outcome research in mainly older, frail, and multimorbid adults. His major scientific interest involve the clinical epidemiology of mainly vulnerable patients with metabolic and endocrine disorders.
Dr. Kutz completed his medical training at the University of Basel in Switzerland. He received his Board Certification for Internal Medicine and Endocrinology and Diabetology in Switzerland and earned a Master degree in Science at Dresden International University and at Harvard School of Public Health in Boston. In 2021, he earned a Master of Public Health in clinical effectiveness at Harvard School of Public Health in Boston.
Dr. Kutz joined in 2021 the Division of Pharmacoepidemiology and Pharmacoeconomics at the Brigham and Women’s Hospital and the Harvard Medical School in Boston for a postdoctoral fellowship supported by an advanced postdoc mobility fellowship from the Swiss National Science Foundation. One of his main focus of interest is the effectiveness and safety of newer antidiabetic medication in people that are usually excluded from clinical trials.
Dr. Kutz is supported by a Postdoc.Mobility grant (P400PM_194479 / 1) from the Swiss National Science Foundation and by an educational grant from Novo Nordisk.